Company Profiles

driven by the PitchBook Platform

Mimetogen Pharmaceuticals

Description

Developer of small molecule drugs for eye treatment. The company is a biotechnology company focused on treatment of dry eye, glaucoma, keratoconus and retinitis pigmentosa.

2005

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$800k

Latest Deal Amount

$1.65M

Total Amount Raised

Description

Developer of small molecule drugs for eye treatment. The company is a biotechnology company focused on treatment of dry eye, glaucoma, keratoconus and retinitis pigmentosa.

Website:

www.mimetogen.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Pharmaceuticals and Biotechnology

Primary Office

1000 de La Gauchetiere Street West Suite 900 Montreal, Quebec H3B 5H4Canada +1 (514) 667-5869
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Mimetogen Pharmaceuticals's full profile, request a free trial.

    Mimetogen Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Mimetogen Pharmaceuticals Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    iNovia CapitalVenture CapitalMinority000 0000000 0000
    Medwell CapitalOtherMinority000 0000000 0000
    MSBi ValorisationVenture CapitalMinority000 0000000 0000
    Schooner CapitalPE/BuyoutMinority000 0000000 0000
    VIMAC VenturesVenture CapitalMinority000 0000000 0000
    iNovia Capital Venture Capital
    Medwell Capital Other
    MSBi Valorisation Venture Capital
    Schooner Capital PE/Buyout
    VIMAC Ventures Venture Capital

    Mimetogen Pharmaceuticals Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Garth Cumberlidge Ph.DCo-Founder, Chief Executive Officer, President & Board Member
    Francois MongrainVice President of Finance & Chief Financial Officer
    Karen Meerovitch Ph.DSenior Director of Clinical Development
    Stephen Pflugfelder MDAdvisor
    Edward Holland MDAdvisor
    Garth Cumberlidge Ph.D Co-Founder, Chief Executive Officer, President & Board Member
    Francois Mongrain Vice President of Finance & Chief Financial Officer
    Karen Meerovitch Ph.D Senior Director of Clinical Development
    Stephen Pflugfelder MD Advisor
    Edward Holland MD Advisor

    Mimetogen Pharmaceuticals Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Cédric Bisson MDSelfBoard Member000 0000
    Garth Cumberlidge Ph.DMimetogen PharmaceuticalsCo-Founder, Chief Executive Officer, President & Board Member000 0000
    Martin Wax MDSelfChairman000 0000
    Sena Biswas Ph.DVIMAC VenturesManaging Director, Life Sciences000 0000
    Cédric Bisson MD Board Member Self
    Garth Cumberlidge Ph.D Co-Founder, Chief Executive Officer, President & Board Member Mimetogen Pharmaceuticals
    Martin Wax MD Chairman Self
    Sena Biswas Ph.D Managing Director, Life Sciences VIMAC Ventures
    Request full access to PitchBook